# Efficacy of ClōSYS® Sensitive Fluoride Toothpaste and ClōSYS® Sensitive Rinse Regimen on MGI, PI and BOP

> **NCT05258721** · PHASE2 · COMPLETED · sponsor: **Rowpar Pharmaceuticals, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Gingivitis
- Periodontitis

## Interventions

- **DRUG:** ClōSYS® Sensitive Fluoride Toothpaste
- **OTHER:** ClōSYS® Sensitive Rinse

## Key facts

- **NCT ID:** NCT05258721
- **Lead sponsor:** Rowpar Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-06
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05258721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05258721, "Efficacy of ClōSYS® Sensitive Fluoride Toothpaste and ClōSYS® Sensitive Rinse Regimen on MGI, PI and BOP". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05258721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*